research alliance

The alliance, led by Singapore-based startup Proteona, also includes several organizations from that city state as well as German research institutes.

The technology uses photostable and bright phosphor-integrated dots for quantitative, amplification-free detection of proteins at cellular and subcellular levels.

The consortium aims to develop assays that can detect biomarkers of pulmonary fibrosis that can be used as early indicators of a treatment's activity.

The computer technology firms will provide BGI Genomics with computational equipment and expertise to support its studies into the genomics of the virus.

The partners will use Medidata's machine learning-based biomarker discovery platform to investigate the amyotrophic lateral sclerosis disease process.

The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.

The alliance comes a few months after Shriners Hospitals established a new genomics institute in Tampa, Florida in partnership with Genome Medical.

The partners will use Noscendo's Disqver next-generation sequencing-based diagnostic platform to characterize antibiotic-resistant pathogens.

As part of the deal, Ionis also took a $10 million equity stake in Empirico and was the lead investor in the company's Series A-2 financing round.